Applied BioCode SARS-CoV-2 Assay Granted FDA EUA
The nucleic acid assay is for the qualitative detection of SARS-CoV-2 nucleic acids in respiratory samples from individuals who are suspected of covid-19.
Read MorePosted by Laurie Bonner | Jun 26, 2020 | Covid 19 |
The nucleic acid assay is for the qualitative detection of SARS-CoV-2 nucleic acids in respiratory samples from individuals who are suspected of covid-19.
Read MorePosted by Laurie Bonner | Jun 25, 2020 | Covid 19 |
The action is an effort to help protect public health from fraudulent products.
Read MorePosted by Laurie Bonner | Jun 24, 2020 | Covid 19 |
Healthcare epidemiologists report using unprecedented methods in response to the unique circumstances resulting from the covid-19 pandemic.
Read MorePosted by Laurie Bonner | Jun 18, 2020 | Hematology Instrumentation |
The Gazelle Diagnostic platform is built around microchip electrophoresis technology that both identifies and quantifies many hemoglobin variants.
Read MorePosted by Laurie Bonner | Jun 17, 2020 | Covid 19 |
Analysis of data from 16 groups of covid-19 patients highlights the need for expansive testing and contact tracing to mitigate the pandemic.
Read More